Randomized trial shows testosterone gel reduces visceral fat in older women — Evidence Review
Published in Obesity Pillars, by researchers from College of Agriculture, Health and Natural Resources
Researched by
— the AI search engine for science
Table of Contents
Older women recovering from hip fractures who used a testosterone gel alongside exercise saw a targeted reduction in visceral fat, according to a recent randomized trial; most related studies in men and mixed populations show testosterone can impact fat distribution, but evidence in older women is limited. The new findings from the original study align in some ways with previous research, though some studies in women have shown different or even opposite effects.
- Several randomized trials in men report that testosterone therapy can reduce visceral fat and improve body composition, but effects in women—especially older, postmenopausal women—are less well established and sometimes differ, possibly due to hormonal and metabolic differences 1 2 3 4.
- Related research highlights that most conventional weight loss strategies fail to target visceral fat specifically and often result in loss of both fat and muscle, a concern particularly relevant for aging adults 7 8 10.
- Some studies in younger women found that long-term testosterone exposure may actually increase visceral fat, especially in those who gain weight, highlighting the need to interpret results in older women and specific clinical contexts with caution 4 11.
Study Overview and Key Findings
As people age, changes in hormone levels and fat distribution—particularly the accumulation of visceral fat—are linked to increased risk of serious health conditions such as diabetes and heart disease. Hip fractures are especially devastating for older women, often resulting in loss of independence and compounding health risks. This study is timely because traditional weight loss approaches do not specifically address the problem of visceral fat accumulation in aging women recovering from injury. The trial sought to evaluate whether a new intervention—topical testosterone gel combined with exercise—could improve body fat distribution during recovery.
| Property | Value |
|---|---|
| Organization | College of Agriculture, Health and Natural Resources |
| Journal Name | Obesity Pillars |
| Authors | Jacob Earp |
| Population | Older women recovering from hip fractures |
| Sample Size | 66 women |
| Methods | Randomized Controlled Trial (RCT) |
| Outcome | Visceral fat levels, overall body fat levels |
| Results | Testosterone gel users had lower visceral fat after six months. |
Literature Review: Related Studies
To better understand how these findings fit into the broader scientific landscape, we searched the Consensus database, which includes over 200 million research papers. The following search queries were used to identify relevant studies:
- testosterone gel visceral fat reduction
- aging belly fat interventions
- hormonal treatment obesity outcomes
Below is a summary table of key topics and findings from the related studies:
| Topic | Key Findings |
|---|---|
| How does testosterone therapy affect visceral fat and body composition in aging adults? | • Testosterone therapy in aging men often reduces visceral fat and increases muscle mass 1 2. • Effects in women are less consistent; some studies show no significant visceral fat reduction, while others report increases in specific contexts 3 4. |
| What interventions effectively target visceral fat in older adults? | • Exercise combined with dietary interventions can improve body composition and reduce abdominal fat, but may not specifically target visceral fat 7 8. • Pharmacological therapies (e.g., GLP-1 agonists) have shown promise for overall fat reduction but with limited data on visceral fat specificity in older adults 13 14 15. |
| What role do sex hormones play in fat distribution and metabolic health in women? | • Estrogen loss after menopause shifts fat distribution toward visceral stores; hormone replacement can counteract some of these effects 11. • Long-term testosterone exposure in young women may increase visceral fat, especially in those who gain weight 4. |
How does testosterone therapy affect visceral fat and body composition in aging adults?
The new study aligns with several randomized controlled trials in men showing that testosterone therapy can reduce visceral fat and improve muscle mass, but the evidence in women, particularly older women, is less clear and sometimes contradictory. While some studies in men demonstrate consistent benefits, including decreased visceral adiposity and improved insulin sensitivity 1 2, findings in women have been mixed, with some reporting no significant effect or even increases in visceral fat under certain conditions 3 4.
- In aging men, testosterone therapy has been shown to decrease visceral fat accumulation and increase fat-free mass 2.
- Some trials in men with type 2 diabetes report reductions in insulin resistance and visceral adiposity following testosterone replacement 1.
- In older women, the evidence is limited; one study found no significant visceral fat reduction with hormone or GH therapy 3.
- Long-term testosterone in young women (e.g., female-to-male transsexuals) increased visceral fat, especially in those who gained weight 4.
What interventions effectively target visceral fat in older adults?
The present study's approach—combining hormone therapy with exercise—addresses a gap because most conventional interventions do not specifically target visceral fat or consider the preservation of muscle mass. Lifestyle interventions (diet and exercise) are generally effective for weight and fat loss in older adults but may not selectively reduce visceral fat, and can risk muscle loss if not combined with resistance training 7 8. Pharmacological treatments, including newer anti-obesity medications, have shown efficacy for overall fat reduction but their impact on visceral fat in aging populations requires more study 13 14 15.
- Lifestyle interventions (diet, exercise) can improve overall body composition and physical function in older adults, though may not focus on visceral fat 7 8 10.
- Bariatric surgery and pharmacological agents (e.g., GLP-1 receptor agonists) are effective for overall weight loss, but specific impacts on visceral fat in older adults are inadequately studied 13 14 15.
- Resistance training combined with dietary interventions helps preserve muscle mass during weight loss in older adults 8 10.
What role do sex hormones play in fat distribution and metabolic health in women?
Sex hormones, particularly estrogen, play a key role in regulating fat distribution in women. After menopause, the loss of estrogen is associated with increased visceral fat accumulation. While estrogen replacement can partially reverse this shift, the effects of androgen (testosterone) therapy in women are less predictable and may depend on age, baseline hormonal status, and weight changes 4 11.
- Loss of estrogen after menopause increases visceral fat and decreases lean body mass; estrogen therapy can counteract these changes 11.
- Long-term testosterone exposure in young women has been associated with increased visceral fat, especially with concurrent weight gain 4.
- Ovarian hormones affect appetite, fat distribution, and energy expenditure, contributing to sex differences in obesity risk and metabolic health 11.
- The interplay between hormonal shifts and fat deposition is complex, with potential differences between men and women and across the lifespan 4 11.
Future Research Questions
While this new study provides important insights into the potential of testosterone gel and exercise to selectively reduce visceral fat in older women recovering from hip fractures, further research is needed. Key areas for future investigation include the long-term safety and efficacy of this approach, its applicability in broader populations, and the underlying mechanisms driving sex-specific responses to hormonal treatments.
| Research Question | Relevance |
|---|---|
| What are the long-term effects of testosterone therapy on visceral fat and muscle mass in older women? | Understanding duration and sustainability of benefits is crucial, as long-term exposure to testosterone may have different effects than short-term use, including potential risks or diminishing returns 2 4. |
| How do hormonal interventions compare to other pharmacological and lifestyle approaches for reducing visceral fat in aging populations? | Comparing efficacy and safety across interventions will help identify optimal strategies for visceral fat reduction while minimizing muscle loss and adverse effects 7 8 13 14. |
| What mechanisms explain the sex-specific responses to testosterone therapy in fat distribution? | Research into hormonal and genetic factors could clarify why testosterone therapy may reduce visceral fat in men but not always in women, and why effects may vary by age and baseline hormone status 3 4 11. |
| Can testosterone gel and exercise improve functional outcomes and quality of life after hip fracture in older women? | Beyond fat reduction, it is important to assess whether this intervention improves physical function, independence, and overall well-being during recovery from major injuries 10. |
| What are the risks and side effects of testosterone therapy in older women, particularly in the context of fracture recovery? | Evaluating the safety profile, including cardiovascular, metabolic, and cancer risks, is essential before widespread use of testosterone therapy in this population 4 13. |